Biomarkers - the Future of Diagnosis in Psychiatry?

Diagnosis of psychiatric disorders currently depends on clinical criteria. In the future the hope is that identification of appropriate biomarkers will enable earlier diagnosis and earlier treatment to improve outcomes for patients. This is particularly critical for schizophrenia to reduce illness severity and improve its course. At EPA2019, the latest research on identifying potential biomarkers in psychiatry was presented in a fascinating state-of-the-art symposium to a packed audience of psychiatrists.

02:54
Download

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References
  1. Biomarkers Definitions Working Group. Clin Pharm Ther 2001
  2. Ratajczak M, et al. Front Psych 2018
  3. Doucet G, et al. Cerebral Cortex 2019
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country